Inspire Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Inspire Pharmaceuticals Ownership

Who owns Inspire Pharmaceuticals?

Inspire Pharmaceuticals is owned by Merck. It was acquired on May 16, 2011.

Was Inspire Pharmaceuticals formerly PE-backed?

Yes. Inspire Pharmaceuticals was formerly owned by 1 private investor.

Inspire Pharmaceuticals Business Overview

Where is Inspire Pharmaceuticals headquartered?

Inspire Pharmaceuticals is headquartered in Durham, North Carolina.

How many employees does Inspire Pharmaceuticals have?

Inspire Pharmaceuticals has 240 employees.

What sector is Inspire Pharmaceuticals in?

Inspire Pharmaceuticals is a life science company.

When was Inspire Pharmaceuticals founded?

Inspire Pharmaceuticals was founded in 1993.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Inspire Pharmaceuticals, Inc.

8081 Arco Corporate Drive, Suite 400,
Durham, North Carolina 27617
United States,
(919) 941-9777
www.inspirepharm.com

Inspire Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new treatments for diseases in the ophthalmic and respiratory areas. In July 2007, Warburg Pincus invested $75 million in Inspire. Founded in 1993 and publicly traded since 2000, Inspire currently markets two ophthalmology products and is developing products for dry eye, cystic fibrosis and glaucoma.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.